⏰ Last chance! ⏰
Abstract submission for the Boston Onconephrology Symposium closes TOMORROW. 🚨
Have a compelling case, QI project, research study?
Now is the time to share it.
🏆 Poster prizes 🌍 International audience
Submit at: asonabstracts2026@gmail.com
@rc_oncneph
Join experts in nephrology, oncology, hematology, pathology, cellular therapy for a truly academic feast.
🚨Deadlines:🚨 📅Travel Scholarship: July 1, 2026 📅 Virtual Registration Awards: August 2026
There’s a tour of Dana-Farber, Brigham, HMS too ✨
Join us for an amazing Onconephrology educational series by the experts
Dr. Idris Boudhabhay and Dr Ala Abudayyeh
✅Immune Check Point Inhibitor Associated AIN: Identification of Neutrophil-Rich Subtype
✅Friday, June 19th EDT
@PAmarapurkar@SabineKaram6
✅Consult for hyperphosphatemia with Phosp of 8-10 mg/dL in a patient with near normal kidney function.
✅What are your differentials ?
@onconephsociety #CaseDiscussion# @UTHealthSANeph
🚨 Call for Abstracts – Onconephrology Symposium 2026 🚨
Have impactful work @ the intersection of cancer & kidney disease?
Submit your🔹 Original Research🔹 Case Reports
🔹 Qi Projects
Exciting Prizes!🏆
📅 June 15 2026
📩asonabstracts2026@gmail.com
@rc_oncneph@onconephsociety
✅Lysozyme nephropathy typically seen in patient’s with acute/ chronic myeloid leukemias
✅Elevated serum and urine lysozyme levels
✅ LM -Proximal tubules filled with eosinophilc granules stained positive for lysozyme
✅Another cause of cancer causing ATI
Difficult but good recent teaching case.
LM- normal appearing glomeruli but proximal tubules filled with eosinophilic granules.
IF- negative.
EM- large number of lysosomes, with degenerative changes.
Lysozyme stain 3 positive in proximal tubules.
Dx: Lysozyme associated-tubulopathy (myelofibrosis/clinical).
Usually see this in patients with CML.
D/D: light chain proximal tubulopathy, but IF & pronase IF are negative.
60-yr old with chronic kidney disease, pulmonary nodules, and JAK2 myelofibrosis.
Evaluation showed high levels of serum lysozyme, and lysozymuria.
Great platform to present your scientific abstracts to @OncnephBoston26
✅Portal opens May 1st until June 15th
Original Research, case reports, quality improvement
@BetterCallSeeth@PAmarapurkar@SabineKaram6 Patrick Hofmann, Abdullah Jalal
Great platform to present your scientific abstracts to @OncnephBoston26
✅Portal opens May 1st until June 15th
Original Research, case reports, quality improvement
@BetterCallSeeth@PAmarapurkar@SabineKaram6 Patrick Hofmann, Abdullah Jalal
Pls join us on @onconephsociety educational series on one of the hot topics
“ T cell mediated therapies in MM and Amyloidosis”
🛑April 24th 2026 12 pm EDT
Presented by Dr Nadia Al Haddad and Dr David Ortiz-Melo
Check out the glomerular pathologies associated with ICI therapy at @MayoClinicNeph . Note that all cases of renal TMA the patients had concurrent or past treatment with another drug that can cause TMA. So always review past or concurrent drugs before call ICI associated TMA!